Endonovo Therapeutics, Inc.
ENDV· OTC
Endonovo Therapeutics, Inc.
- Close
- Dec 22, 2023
- Market cap
- $3.19M
- 318.75M shares
- Filings
- 502
Price
Dec 22, 2023 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | $135,355 | reported | |
| FY 2021 | 2021-12-31 | $73,105 | reported | |
| FY 2020 | 2020-12-31 | $165,796 | reported | |
| FY 2019 | 2019-12-31 | $310,164 | reported | |
| FY 2018 | 2018-12-31 | $83,263 | reported | |
| FY 2015 | 2015-12-31 | $4,265 | reported | |
| FY 2014 | 2014-12-31 | $24,192 | reported | |
| FY 2013 | 2013-12-31 | $22,896 | reported | |
| FY 2012 | 2012-12-31 | $30,581 | reported | |
| FY 2011 | 2011-12-31 | $45,544 | reported | |
| FY 2010 | 2010-12-31 | $51,199 | reported |
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
